TNFRSF1B +676 T>G polymorphism predicts survival of non-Small cell lung cancer patients treated with chemoradiotherapy

[1]  Caicun Zhou,et al.  Serum cytokine levels in patients with advanced non-small cell lung cancer: correlation with treatment response and survival , 2011, Medical Oncology.

[2]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[3]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[4]  A. Kuwahara,et al.  TNFRSF1B A1466G genotype is predictive of clinical efficacy after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma , 2010, Journal of experimental & clinical cancer research : CR.

[5]  Lei Yao,et al.  TNFα −308 G/A polymorphism is associated with breast cancer risk: a meta-analysis involving 10,184 cases and 12,911 controls , 2010, Breast Cancer Research and Treatment.

[6]  R. D. Mittal,et al.  Association of tumour necrosis factor‐α gene (T‐1031C, C‐863A, and C‐857T) polymorphisms with bladder cancer susceptibility and outcome after bacille Calmette‐Guérin immunotherapy , 2009, BJU international.

[7]  J. Kładny,et al.  Clinical characteristics of tumors derived from colorectal cancer patients who harbor the tumor necrosis factor alpha-1031T/T and NOD2 3020insC polymorphism. , 2009, Cancer epidemiology.

[8]  M. Martel,et al.  Single nucleotide polymorphism at rs1982073:T869C of the TGFbeta 1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  E. Nkenke,et al.  Association of polymorphisms in Tumor Necrosis Factor Alpha and Beta genes with increased risk for oral cancer. , 2009, Anticancer research.

[10]  Jack A. Taylor,et al.  SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies , 2009, Nucleic Acids Res..

[11]  A. Tomovic,et al.  TNF-alpha-308 promotor polymorphism in patients with chronic obstructive pulmonary disease and lung cancer. , 2009, Neoplasma.

[12]  Manuela Zucknick,et al.  Systemic inflammatory response predicts prognosis in patients with advanced-stage colorectal cancer. , 2008, Clinical colorectal cancer.

[13]  Satya N. Das,et al.  Association of TNF-alpha and TNFR1 promoters and 3' UTR region of TNFR2 gene polymorphisms with genetic susceptibility to tobacco-related oral carcinoma in Asian Indians. , 2008, Oral oncology.

[14]  Lujun Zhao,et al.  Inhibition of the Tumor Necrosis Factor-α Pathway Is Radioprotective for the Lung , 2008, Clinical Cancer Research.

[15]  L. Larocca,et al.  Polymorphism in cytokine genes as prognostic markers in Hodgkin's lymphoma. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

[16]  M. Collado,et al.  Variable number of tandem repeats of TNF receptor type 2 promoter as genetic biomarker of susceptibility to develop invasive pulmonary aspergillosis. , 2007, Human immunology.

[17]  S. Chanock,et al.  Genetic variation in tumor necrosis factor and lymphotoxin-alpha (TNF–LTA) and breast cancer risk , 2007, Human Genetics.

[18]  V. Baniasadi,et al.  Association of −308 TNF‐α promoter polymorphism with type 1 diabetes in North Indians , 2006 .

[19]  I. Endo,et al.  Predicting 5‐fluorouracil chemosensitivity of liver metastases from colorectal cancer using primary tumor specimens: Three‐gene expression model predicts clinical response , 2006, International journal of cancer.

[20]  G. Fontanini,et al.  Tumour necrosis factor-α: prognostic role and relationship with interleukin-8 and endothelin-1 in non-small cell lung cancer , 2006 .

[21]  Wei Chen,et al.  Association of TNF-α polymorphism with susceptibility to and severity of non-small cell lung cancer , 2006 .

[22]  G. Fontanini,et al.  Tumour necrosis factor-alpha: prognostic role and relationship with interleukin-8 and endothelin-1 in non-small cell lung cancer. , 2006, International journal of molecular medicine.

[23]  M. Chou,et al.  Association of TNF-alpha polymorphism with susceptibility to and severity of non-small cell lung cancer. , 2006, Lung cancer.

[24]  V. Baniasadi,et al.  Association of -308 TNF-alpha promoter polymorphism with type 1 diabetes in North Indians. , 2006, International journal of immunogenetics.

[25]  D. Gandara,et al.  Integration of Novel Therapeutics into Combined Modality Therapy of Locally Advanced Non–Small Cell Lung Cancer , 2005, Clinical Cancer Research.

[26]  L. Chouchane,et al.  A functional polymorphism of the tumor necrosis factor receptor-II gene associated with the survival and relapse prediction of breast carcinoma. , 2005, Cytokine.

[27]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[28]  P. Rosenstiel,et al.  The Met-196 → Arg Variation of Human Tumor Necrosis Factor Receptor 2 (TNFR2) Affects TNF-α-induced Apoptosis by Impaired NF-κB Signaling and Target Gene Expression* , 2005, Journal of Biological Chemistry.

[29]  Wun-Jae Kim,et al.  Genotypes of TNF-alpha, VEGF, hOGG1, GSTM1, and GSTT1: useful determinants for clinical outcome of bladder cancer. , 2005, Urology.

[30]  P. Rosenstiel,et al.  The Met-196 -> Arg variation of human tumor necrosis factor receptor 2 (TNFR2) affects TNF-alpha-induced apoptosis by impaired NF-kappaB signaling and target gene expression. , 2005, The Journal of biological chemistry.

[31]  M. Stolte,et al.  Allele 2 of the interleukin-1 receptor antagonist gene is associated with early gastric cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  Wun-Jae Kim,et al.  Association of bladder tumors and GA genotype of -308 nucleotide in tumor necrosis factor-alpha promoter with greater tumor necrosis factor-alpha expression. , 2004, Urology.

[33]  A. Bateman,et al.  Cytokine gene polymorphisms and breast cancer susceptibility and prognosis. , 2004, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[34]  T. Ottenhoff,et al.  Is there a future for TNF promoter polymorphisms? , 2004, Genes and Immunity.

[35]  G. Jackson,et al.  Tumour necrosis factor receptor type II 196M/R genotype correlates with circulating soluble receptor levels in normal subjects and with graft-versus-host disease after sibling allogeneic bone marrow transplantation1 , 2003, Transplantation.

[36]  B. Aggarwal.  Signalling pathways of the TNF superfamily: a double-edged sword , 2003, Nature Reviews Immunology.

[37]  C. Caldas,et al.  A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. , 2003, Gastroenterology.

[38]  N. Willich,et al.  Modulation of radiation-induced tumour necrosis factor α (TNF-α) expression in the lung tissue by pentoxifylline , 2002 .

[39]  F. Greene.  The American Joint Committee on Cancer: updating the strategies in cancer staging. , 2002, Bulletin of the American College of Surgeons.

[40]  N. Willich,et al.  Modulation of radiation-induced tumour necrosis factor alpha (TNF-alpha) expression in the lung tissue by pentoxifylline. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[41]  T. Horiuchi,et al.  Association of tumor necrosis factor receptor type II polymorphism 196R with Systemic lupus erythematosus in the Japanese: molecular and functional analysis. , 2001, Arthritis and rheumatism.

[42]  A. Hajeer,et al.  Influence of TNFa gene polymorphisms on TNFa production and disease , 2001 .

[43]  R. Tsuchiya,et al.  Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience. , 2001, The Annals of thoracic surgery.

[44]  J. Chun,et al.  The -238 tumor necrosis factor-alpha promoter polymorphism is associated with decreased susceptibility to cancers. , 2001, Cancer letters.

[45]  S. Remadi,et al.  Genetic variation in the tumor necrosis factor-alpha promoter region and in the stress protein hsp70-2: susceptibility and prognostic implications in breast carcinoma. , 2001, Cancer.

[46]  A. Hajeer,et al.  Influence of TNFalpha gene polymorphisms on TNFalpha production and disease. , 2001, Human immunology.

[47]  A. Hajeer,et al.  TNF‐α gene polymorphism: Clinical and biological implications , 2000 .

[48]  C. Angeletti,et al.  Tumour necrosis factor- α and transforming growth factor- β are significantly associated with better prognosis in non-small cell lung carcinoma: putative relation with BCL -2-mediated neovascularization , 2000, British Journal of Cancer.

[49]  A. Hajeer,et al.  TNF-alpha gene polymorphism: clinical and biological implications. , 2000, Microscopy research and technique.

[50]  T. Shimosegawa,et al.  Crohn's disease is associated with novel polymorphisms in the 5'-flanking region of the tumor necrosis factor gene. , 1999, Gastroenterology.

[51]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[52]  B. Kallakury,et al.  Prognostic significance of tumor necrosis factors and their receptors in nonsmall cell lung carcinoma , 1998, Cancer.

[53]  S. Fox,et al.  Association of tumour necrosis factor alpha and its receptors with thymidine phosphorylase expression in invasive breast carcinoma. , 1998, British Journal of Cancer.

[54]  M. Hibberd,et al.  Genetic influence on cytokine production in meningococcal disease , 1997, The Lancet.

[55]  H. Mcdevitt,et al.  Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[56]  D. Goeddel,et al.  Physical mapping and genomic structure of the human TNFR2 gene. , 1996, Genomics.

[57]  D. Miles,et al.  Expression of tumour necrosis factor (TNFα) and its receptors in benign and malignant breast tissue , 1994 .

[58]  L. Tartaglia,et al.  Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. , 1993, The Journal of biological chemistry.

[59]  W. Foulkes,et al.  Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression. , 1993, The Journal of clinical investigation.